Cullinan Therapeutics, Inc.CGEMNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average, structural decline.
Left:
||||
Free cash flow yield
Latest
-22.19%
↑ 28% above average
Average (6y)
-30.86%
Historical baseline
Range
High:-2.29%
Low:-68.76%
CAGR
-14.7%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | -22.19% | +30.2% |
| 2023 | -31.80% | -18.5% |
| 2022 | -26.82% | -316.4% |
| 2021 | -6.44% | -181.5% |
| 2020 | -2.29% | +96.7% |
| 2019 | -68.76% | -19.1% |
| 2018 | -57.71% | - |